Charleston, SC -- (SBWIRE) -- 12/10/2013 -- Hot Shot Stock Alerts is a market and commodities news and marketing web service, providing investing news, business news, headline news, news alerts, personal finance, stock market, and press releases. Hot Shot Stock Alerts carries you the most fascinating reviews and research reports regarding following stocks: DUNDEE PRECIOUS METL (OTCMKTS:DPMLF), TITAN MEDICAL INC (OTCMKTS:TITXF), Brainstorm Cell Therapeutics Inc (OTCBB:BCLI), Cellceutix Corp (OTCMKTS:CTIX)
Shares of DUNDEE PRECIOUS METL (OTCMKTS:DPMLF) traded in a range of $2.36 to $2.45, completing the day up +2.11% to $2.42. The total volume of shares exchanged was 92,075 million. The day started out with an opening price of $2.37 versus prior close of $2.37. The company has the total market capitalization is now about $329.34 million.
Dundee Precious Metals Inc. engages in acquisition, exploration, development, mining, and processing of precious metals. It primarily explores for gold, copper, silver, and zinc deposits.
Why Should Investors Buy DPMLF After The Recent Gain? Just Go Here and Find Out
With the latest decline of -10.03%, TITAN MEDICAL INC (OTCMKTS:TITXF) now has YTD performance -23.73% which for the week is negative at -8.52%. The total number of shares traded on the latest trading day was about 586,383 shares, and changed hands at price range of $0.81 to $1.06 apiece. The company ended previous trading at $0.927.
Titan Medical Inc., a development stage company, engages in the design and development of Amadeus robotic surgical system for application in minimally invasive surgery (MIS).
Has TITXF Found The Bottom and Ready To Move Up? Find Out Here
Brainstorm Cell Therapeutics Inc (OTCBB:BCLI) finished last trade at $0.150, losing -14.83%. Trading volume recorded for this company was about 3.29 million shares as compared to its average volume of 201,158 shares. The share price plunged almost -21.11% in the last one month while its 52 week high is $0.27. The company has the total of 176.24 million outstanding shares while its market capitalization is now about $26.42 million.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in developing adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis.
Why Should Investors Buy BCLI After the Recent Fall? Just Go Here and Find Out
Cellceutix Corp (OTCMKTS:CTIX) closed latest trading day at $1.62, up +2.41%, on volume of over 253,454 shares. The stock fell -0.27% in the last 5 days. Its average trading volume is 163,641 shares. In the time frame of the last one month, the share-price has dropped almost -11.58%. Its market capitalization was $192.06 million.
Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
What was the Moving Force behind CTIX On Bullish Run? Read This Research Report
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the HotShotStockAlerts.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
HotShotStockAlerts.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Read full Disclaimer at: http://hotshotstockalerts.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)